Containment Advisory Group

The Containment Advisory Group acts as an advisory body to the Director-General of WHO, and makes recommendations on technical issues related to the implementation of the Global Action Plan to minimize poliovirus facility associated risk after the type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use (GAPIII).

Reports of the Containment Advisory Group

Teleconference of the Containment Advisory Group (CAG TC5) on definition of novel OPV strains and GAPIII containment requirements for nOPV1 and nOPV3 development and production.
20 March 2020

Fourth meeting of the Containment Advisory Group
15-16 July 2019, Geneva, Switzerland

Criteria for the evaluation of improved ‘safety’ of novel poliovirus strains to determine the containment requirements for their storage and handling

Third meeting of the Containment Advisory Group
13-14 December 2018, Geneva, Switzerland

Ad hoc teleconference of the Containment Advisory Group (CAG TC4) on Tertiary Safeguards of Facility Location and Associated Environmental Controls Described in GAPIII
14 August 2018

Teleconference of the Containment Advisory Group (CAG TC3) on nOPV2 candidate vaccines and S19 – poliovirus type 2 strains
7 June 2018

Addendum to the Report of the Teleconference of the Containment Advisory Group (CAG TC3) on nOPV2 candidate vaccines and S19 – poliovirus type 2 strains

Teleconference of the Containment Advisory Group (CAG TC2) on Novel Poliovirus Strains
8 March 2018

Teleconference of the Containment Advisory Group (CAG TC1) on Showers
25 January 2018

Second meeting of the Containment Advisory Group
28-30 November 2017, Geneva, Switzerland

First meeting of the Containment Advisory Group
19-20 June 2017, Geneva, Switzerland